Carcinoma vulva: Ten years experience in a teaching institution of North India

Introduction: Vulvar carcinoma is primarily a disease of post-menopausal women. Surgery is a primary treatment strategy. Chemotherapy and radiotherapy are a part of multimodal therapy. Presently, there is a shift towards neoadjuvant chemotherapy or radiotherapy so as to decrease the surgical morbidi...

Full description

Bibliographic Details
Main Authors: Lajya Devi Goyal, Balpreet Kaur, Shivali Bhalla, Pardeep Garg
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=4;spage=654;epage=659;aulast=Goyal
_version_ 1797775584708788224
author Lajya Devi Goyal
Balpreet Kaur
Shivali Bhalla
Pardeep Garg
author_facet Lajya Devi Goyal
Balpreet Kaur
Shivali Bhalla
Pardeep Garg
author_sort Lajya Devi Goyal
collection DOAJ
description Introduction: Vulvar carcinoma is primarily a disease of post-menopausal women. Surgery is a primary treatment strategy. Chemotherapy and radiotherapy are a part of multimodal therapy. Presently, there is a shift towards neoadjuvant chemotherapy or radiotherapy so as to decrease the surgical morbidities. Objective: To study the surgical outcome and prognostic factors in Ca vulva patients. Methodology: A retrospective analysis of 19 vulvar cancer patients, surgically treated at a teaching institution of Punjab (2009–2019). Results: Mean age of the patients was 60.95 years. Ulcerative swelling (89.5%) over labia majora (73.7%) was the main presenting symptom. Radical vulvectomy-bilateral IFLN dissection was performed in 74% patients, hemivulvectomy-unilateral IFLN dissection in 21% patients and wide local excision in one patient. Squamous cell carcinoma was detected in all, and one had verrucous carcinoma. Thirty-seven per cent patients had FIGO stage III disease, 31.5% - stage II and 31.5% - stage I. On HPE, 78.57% (11/14) patients had positive nodes and two had ECS. Only 5/9 (55.5%) cases could receive PORT. Seven patients defaulted follow-up. Two developed nodal metastasis, and seven women developed recurrence. One patient with regional recurrence faced demise during RT course. In 10/19 regular follow-up patients, four are alive and disease free, five patients are on palliative chemoradiation, and one is undergoing adjuvant radiotherapy for regional recurrence. Estimated 5-year overall survival is 83.33%. Conclusion: Tumour stage, nodal positivity and nodal ECS were poor prognostic factors. Radical surgery-extensive groin node dissection causes significant morbidity; hence, studies evaluating the role of neoadjuvant treatment are needed so as to modify current treatment practices. HPV vaccination as a preventive measure and a thorough and extensive evaluation of patients with suspicious signs in vulvar disease is needed.
first_indexed 2024-03-12T22:37:47Z
format Article
id doaj.art-ce44acdc0b9142c0a5e9f3bd773bedd7
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-03-12T22:37:47Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-ce44acdc0b9142c0a5e9f3bd773bedd72023-07-21T11:37:16ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632023-01-0112465465910.4103/jfmpc.jfmpc_1731_22Carcinoma vulva: Ten years experience in a teaching institution of North IndiaLajya Devi GoyalBalpreet KaurShivali BhallaPardeep GargIntroduction: Vulvar carcinoma is primarily a disease of post-menopausal women. Surgery is a primary treatment strategy. Chemotherapy and radiotherapy are a part of multimodal therapy. Presently, there is a shift towards neoadjuvant chemotherapy or radiotherapy so as to decrease the surgical morbidities. Objective: To study the surgical outcome and prognostic factors in Ca vulva patients. Methodology: A retrospective analysis of 19 vulvar cancer patients, surgically treated at a teaching institution of Punjab (2009–2019). Results: Mean age of the patients was 60.95 years. Ulcerative swelling (89.5%) over labia majora (73.7%) was the main presenting symptom. Radical vulvectomy-bilateral IFLN dissection was performed in 74% patients, hemivulvectomy-unilateral IFLN dissection in 21% patients and wide local excision in one patient. Squamous cell carcinoma was detected in all, and one had verrucous carcinoma. Thirty-seven per cent patients had FIGO stage III disease, 31.5% - stage II and 31.5% - stage I. On HPE, 78.57% (11/14) patients had positive nodes and two had ECS. Only 5/9 (55.5%) cases could receive PORT. Seven patients defaulted follow-up. Two developed nodal metastasis, and seven women developed recurrence. One patient with regional recurrence faced demise during RT course. In 10/19 regular follow-up patients, four are alive and disease free, five patients are on palliative chemoradiation, and one is undergoing adjuvant radiotherapy for regional recurrence. Estimated 5-year overall survival is 83.33%. Conclusion: Tumour stage, nodal positivity and nodal ECS were poor prognostic factors. Radical surgery-extensive groin node dissection causes significant morbidity; hence, studies evaluating the role of neoadjuvant treatment are needed so as to modify current treatment practices. HPV vaccination as a preventive measure and a thorough and extensive evaluation of patients with suspicious signs in vulvar disease is needed.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=4;spage=654;epage=659;aulast=Goyalradical vulvectomyradiotherapysentinel lymph node biopsysquamous cell carcinoma
spellingShingle Lajya Devi Goyal
Balpreet Kaur
Shivali Bhalla
Pardeep Garg
Carcinoma vulva: Ten years experience in a teaching institution of North India
Journal of Family Medicine and Primary Care
radical vulvectomy
radiotherapy
sentinel lymph node biopsy
squamous cell carcinoma
title Carcinoma vulva: Ten years experience in a teaching institution of North India
title_full Carcinoma vulva: Ten years experience in a teaching institution of North India
title_fullStr Carcinoma vulva: Ten years experience in a teaching institution of North India
title_full_unstemmed Carcinoma vulva: Ten years experience in a teaching institution of North India
title_short Carcinoma vulva: Ten years experience in a teaching institution of North India
title_sort carcinoma vulva ten years experience in a teaching institution of north india
topic radical vulvectomy
radiotherapy
sentinel lymph node biopsy
squamous cell carcinoma
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=4;spage=654;epage=659;aulast=Goyal
work_keys_str_mv AT lajyadevigoyal carcinomavulvatenyearsexperienceinateachinginstitutionofnorthindia
AT balpreetkaur carcinomavulvatenyearsexperienceinateachinginstitutionofnorthindia
AT shivalibhalla carcinomavulvatenyearsexperienceinateachinginstitutionofnorthindia
AT pardeepgarg carcinomavulvatenyearsexperienceinateachinginstitutionofnorthindia